
The Pediatric Translational Research program is focused on using lab discoveries to develop treatments and diagnostics that will help children and young adults in the clinical setting. These include respiratory conditions such as asthma, severe asthma, bronchopulmonary dysplasia, opioid-induced respiratory depression, primary ciliary dyskinesia, cystic fibrosis and aerodigestive disorders.
Members of this group and their colleagues have discovered exciting pathways leading to the development of several treatments and diagnostic modalities that are being evaluated for use in each of these areas. A few of these treatments and modalities have reached the clinical study phase of research, which includes adults as well, as highlighted in the clinical projects listed below.
A major goal of this program is to help pediatric investigators across all disciplines at the Wells Center to collaborate with engineers and other scientists, translating new insights and discoveries into products that will improve the health of children.
The following translational research study projects are designed to develop personalized precision care and treatments for people with asthma and cystic fibrosis, taking place in children and adults.